Flexion raises $65M in IPO

Flexion Therapeutics (FLXN) has raised $65M in its Nasdaq IPO by selling 5M shares at $13, within the range of $12-14.

Flexion, which develops osteoarthritis drugs, has a market cap of $192M.

There's also a greenshoe option of 750,000 shares.

Flexion's shares are due to start trading today.

IPO Previews: Don Dion, IPOdesktop


From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs